Cite
HARVARD Citation
Gogas, H. et al. (2016). MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer. Journal of translational medicine. 14 (1), pp. 1-17. [Online].